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Abstract  
This article is the first of three articles that will deal with pacing. The history 
and background leading to pacemakers as we know them is briefly discussed.  
 
Introduction  
The history of cardiac pacing therapy must be viewed within the broader 
framework of electro-diagnosis and electro-therapy. Moreover it can be 
observed that the development of electro-therapy usually preceded the 
understanding of what was actually occurring within the heart.  
Electro-therapy has a simple core concept: the use of an outside source of 
electricity to stimulate human tissue in various ways to produce a beneficial 
therapeutic effect. This has shown a prolonged, halting development through 
the ages, sometimes being looked upon as mysterious magic produced by 
complex machines.  
Over the last fifty years or so, electro-therapy has shown a very rapid, almost 
explosive, development with many innovators contributing to a whole series of 
"firsts". This was the consequence of a remarkable co-operation among 
surgeons, physicians, engineers, chemists, businessmen and patients. The 
field of paediatric open heart surgery gave a major impetus to the 
development of pacemakers since heart block often accompanied impeccably 
performed intra-cardiac repairs of congenital defects.  
Most of the scientists and physicians involved in electro-therapy faced 
significant criticism and sometimes even derision by the contemporary 
scientific community. Yet the speciality moved steadily on gaining medical 
respectability and now helps countless patients all over the world.  
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Antiquity  
Hippocrates (460 – 375 BC) (Fig. 1)  
 
"Those who suffer from frequent and strong faints without any manifest cause 
die suddenly"  
Fig. 1: Hippocrates (460 - 375 BC) 
 
 
Aristotle (384 – 322 BC) (Fig. 2)  
Aristotle saw the heart as "the source of all movement, since the heart links 
the soul with the organs of life". Remarkably accurite as a description of 
cardiovascular physiology!  
 
Fig. 2: Aristotle (384 - 322 BC) 
 
 
The pulse  
In ancient China (280 BC), Wang Shu-he wrote 10 books about the pulse. 
The Greeks called the pulse "sphygmos", and sphygmology thus deals with 
the theory of pulse. Galen, in Roman times, interpreted the various types of 
pulses according to current thought, that each organ in each disease has its 
own form of pulse.  
 
Ancient Roman physicians  
These treated patients suffering from pain and acute gout with electric rays 
(Fig. 3) and other electrically-charged sea creatures. Electric rays are 
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cartilaginous fish with two large, kidney-shaped electric organs on either side 
of their head. These organs are capable of generating strong electric shocks, 
which are administered at will to deter predators or capture prey.  
 
Fig. 3: Electric Rays 
 
 
1580  
Geronimo Mercuriale (Fig. 4) formulated the concept of syncope and 
demonstrated its connection with a slow pulse rate: "Ubi pulsus sit rarus 
semper expectanda est syncope".  
 
Fig. 4: Geronimo Mercuriale (1530 - 1606) 
 
 
1600  
William Harvey restarted an arrested pigeon’s heart by a simple flick of the 
finger. In 1628 he described the circulation (Fig. 5).  
O Aquilina. A brief history of cardiac pacing. Images Paediatr Cardiol. 2006 Apr-Jun; 8(2): 17–81.  
 20 
 
Fig. 5: William Harvey and the circulation 
 
1713  
While the anatomy and physiology of the heart were being studied, others 
analysed the peripheral pulse, which was the mechanical expression of 
cardiac activity. In 1713, Micheal Bernhard Valentini used pulse diagrams and 
pulse theory in the general practice of medicine (Fig.6).  
 
Fig. 6: A pulse diagram by Valentini 
 
 
Early cardiac electrotherapy  
1640’s  
Publications speculating on the bio-electric nature of the cardiovascular 
system appeared.  
1774  
The first reference to external electrical stimulation of the heart in the 
Registers of the Royal Human Society of London. The physician was Squires 
and the patient was a young girl.  
1775  
The Danish physicist Nickolev Abildgaard conducted the first studies on the 
effects of electrical energy when applied to the body. He placed electrodes on 
the sides of a hen’s head and applied an electric discharge which caused it to 
fall dead. Application of electrodes over various parts of the hen’s body failed 
to reanimate the bird, until they were placed across the chest. In this position 
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they presumably defibrillated the heart after which the hen staggered onto its 
feet and walked away (Fig.7).  
 
Fig. 7: Stimulation device (1788) 
 
 
1791  
Luigi Galvani (Fig.8), an Italian physician and natural scientist, announced 
that electricity was inherent in organic tissue. He published the experimental 
findings of electrical phenomena in frog muscles and frog hearts making a 
fundamental contribution to modern cardiac electrophysiology.  
 
Fig. 8: Luigi Galvani (1737 - 1798) 
 
 
There was general agreement that electricity had a pronounced effect on the 
heart (Fig.9, 10).  
 
Fig. 9: Galvani's electrostatic nerve stimulator 
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Fig. 10: Galvani’s forceps 
 
 
1797  
Alexander von Humboldt found a dead bird in his garden and placed a blade 
of zinc in the beak and a shaft of silver into the rectum. An electric shock 
caused the bird to flap its wings and attempt to walk. He also tried the 
experiment on himself with unpleasant consequences.  
The 19th century  
 
Rudimentary forms of electrical stimulation were used by physicians 
sporadically to treat cardiac disease in numerous ways without any 
standardisation. The crude technology was however far ahead of the 
understanding of heart disease and a very wide range of effects were 
documented.  
 
1800  
The Italian physicist, Alessandro Volta (Fig. 11) showed that current electricity 
could be produced by the contact of dissimilar metals and devised the first 
electric battery for low-voltage high-current stimulation, the "voltaic pile" (Fig. 
12). For the first time, electricity could be produced by means other than 
through electrostatic machines. He also gave his name to one of the basic 
physical units of electricity: the Volt, unit of electromotive force.  
 
Fig. 11: Alessandro Volta (1745 - 1827) 
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Fig. 12: The Volta Pile 
 
 
1800 – 1802  
Marie Francois Xavier Bichat (Fig. 13) and Nysten reported experiments on 
decapitated humans in whom they were able to make hearts beat again using 
electric current. They had no shortage of experimental material during the 
French Revolution.  
 
Fig. 13: Marie Francois Xavier Bichat (1701 - 1802) 
 
 
1804  
Aldini (1762 - 1834) (Fig.14), described the alleviation of cardiac syncope 
through "galvanic energy" utilising animal and cadaver studies.  
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Fig. 14: Aldini (1762 - 1834) 
 
 
1855  
Rudolph Albert von Kollicker published work on the "action currents" of the 
heart and showed that a definite electric current was produced with each beat 
of a frog’s heart.  
1872  
Duchenne de Boulogne (1806 - 1875), successfully resuscitated a child who 
had drowned by attaching one electrode to a leg while rhythmically tapping 
the precordium with another electrode.  
1882  
A golden opportunity for clinical and scientific experimentation arose in 1882. 
A 46-year old female patient arrived in the clinic of Hugo Von Ziemssen 
(Fig.15). She was an unskilled labourer called Catharina Serafin from Upper 
Silesia in Prussia (Fig.16). A chest tumour had been excised together with the 
left anterior part of her thoracic wall thus exposing her heart, which could be 
seen through a thin layer of skin. Von Ziemssen stimulated her heart using 
electric current and could change her heart rate at will. The recordings (Fig. 
17) clearly show that ventricular activity was being produced by electrical 
impulses applied to the cardiac surface: extremely interesting but potentially 
fatal investigations!  
 
Fig. 15: Hugo Von Ziemssen (1829 - 1902) 
 
 
O Aquilina. A brief history of cardiac pacing. Images Paediatr Cardiol. 2006 Apr-Jun; 8(2): 17–81.  
 25 
Fig. 16: Catharina Serafin 
 
 
Fig. 17: Catharina’s cardiac activity 
 
 
Late 1800’s  
 
The English doctor John Mac William (Fig. 18) collected and analysed all the 
scattered data available at that time and laid down the basic concepts of 
modern pacing accurately identifying many of the treatment’s problems.  
 
Fig. 18: John Mac William 
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In 1889 he described the application of electricity across the chest to "excite 
rhythmic contraction… to stimulate by direct means the action of the heart 
which has been suddenly enfeebled or arrested in diastole by causes of a 
temporary or transient character".  
Medicine had its first integrated theory of cardiac pacing yet another 20 to 30 
years had to elapse before this theory resulted in effective therapy. In 
particular it had to await significant further medical discoveries (cardiac 
structure, physiology and conduction pathways) and technical progress (the 
electrocardiogram, lab stimulators).  
 
The Gerbezius-Morgagni-Adams-Stokes Syndrome  
1717  
Marcus Gerbazius (1658 - 1718), a Slovenian physician, described the 
symptoms of bradycardia due to complete atrio-ventricular block.  
1761  
The Italian Giovanni Battista Morgagni (1682 - 1771) (Fig.19), founder of 
pathological anatomy, provided a clinical description of circulatory arrest and 
implying a causal relationship between a slow pulse and a syncopal attack. 
 
  
 
Fig. 19: Giovanni Battista Morgagni (1682 - 1771) 
 
 
 
 
 
1827  
The Irish surgeon Robert Adams (1791 - 1875) described a patient with 
repeated apoplectic attacks and a slow pulse. He was the first to realise that 
cerebral symptoms may be caused by cardiac rhythm disorders.  
1846  
William Stokes (1804 - 1878) (Fig.20), another Irishman, described once more 
the pseudo-apoplectic loss of consciousness and bradycardia in a patient, 
giving further observations on this condition and a detailed analysis of Adam’s 
case.  
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Fig. 20: William Stokes (1804 - 1878) 
 
 
Atrio-Ventricular Block  
1899  
Karel Frederik Wenckebach (Fig.21), a Dutchman, described type I second 
degree atrio-ventricular block in humans using sphygmographic methods of 
the radial pulse (the electrocardiogram was not yet in clinical use).  
 
Fig. 21: Karel Frederik Wenckebach 
 
1906  
John Hay (Fig. 22) from Liverpool, England, published a case report of type II 
second degree atrio-ventricular block documenting his findings again without 
the benefit of electrocardiography. He utilised simultaneous tracings from the 
radial artery and the jugular venous pulse.  
 
Fig. 22: John Hay 
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1924  
Woldemar Mobitz provided the classification of second degree atrio-
ventricular blocks utilising the electrocardiogram, hence documenting 
Wenckebach’s and Hay’s findings.  
 
The Electrocardiograph  
 
Over the late 1800’s – early 1900’s, cardiology witnessed a great 
technological breakthrough that was to have a major effect on the 
understanding of arrhythmias and hence on the development of specific 
therapy including pacing: the invention of the electrocardiograph.  
 
1887  
The physiologist Augustus Desire’ Waller (Fig. 23) working in St. Mary’s 
Hospital, London, recorded the first human surface electrocardiogram using 
the Lippmann capillary electrometer to deflect a light beam (Fig. 24, 25). 
Alexander Muirhead may have been the first to record a human 
electrocardiogram but Waller was the first to do so in a clinico-physiologic 
setting, publishing reports and acquiring extensive experience.  
 
Fig. 23: Augustus Desire Waller 
 
 
Fig. 24: Lippmann 
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Fig. 25: Lippmann’s electrometer 
 
 
Waller had learnt that "each beat of the heart gives an electric change, 
beginning at one end of the organ and ending at the other". He was convinced 
that he could measure these "electromotive properties of the heart" from the 
skin surface and proceeded to do so with the electrometer connected 
between the left and right hands or between the front and back paws of his 
pet bulldog, Jimmie (Fig.26).  
 
Fig. 26: Waller’s recording setup 
 
 
The clinical significance of the electrocardiogram (Fig. 27, 28) was not 
recognised at the time and Waller himself said: "I do not imagine that 
electrocardiography is likely to find any very extensive use in the hospital. It 
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can at most be of rare and occasional use to afford a record of some rare 
anomaly of cardiac action."  
 
Fig. 27: First ECG 
 
 
Fig. 28: Early Waller ECG’s and apparatus 
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He would often use Jimmie as the subject when he demonstrated his method 
at lectures by dipping his legs in pots of saline, which served as the 
electrodes (Fig.29). A question was raised at the House of Commons and this 
"cruel procedure" risked being dealt with by the "Cruelty to Animals Act" of 
1876. The scientist countered these objections and remarked: "If my 
honourable friend had ever paddled in the sea, he will appreciate fully the 
sensation obtained thereby from this simple pleasurable experience." (Fig. 30) 
Jimmie never complained anyway! Waller is said to have been quite informal 
and loved entertaining and dashing around with the newly invented motor car.  
 
Fig. 29: Jimmie with its proud owner 
 
 
Fig. 30: From the records of the House of Commons 
 
 
O Aquilina. A brief history of cardiac pacing. Images Paediatr Cardiol. 2006 Apr-Jun; 8(2): 17–81.  
 32 
1892  
Another physiologist, Willem Einthoven (1860 – 1927) (Fig. 31), shares the 
honour with Waller of having founded this new diagnostic modality. Einthoven 
recorded the first human electrocardiogram in Europe on April 11th, 1892 
using the Lippmann capillary electrometer. He initially indicated the four 
observed deflections with the characters A, B, C, D but later adopted the 
middle characters of the alphabeth: P, Q, R, S and T (Fig. 32).  
 
Fig. 31: Willem Einthoven (1860 – 1927) 
 
 
Fig. 32: Early Einthoven ECG’s 
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In 1902, he made the first direct recording of the true human 
electrocardiogram using a modified string galvanometer (Fig. 33).  
 
Fig. 33: The String Galvanometer 
 
 
An extremely thin and light weight quartz "string" was silvered to reflect a 
beam of light and suspended vertically in a strong magnetic field. The very 
small electric currents generated by the heart were collected from the arms 
and legs and conducted to the "string" which was deflected laterally by the 
passage of this fluctuating current. The "string" threw a a vertical shadow, 
magnified by a microscope, onto a metal plate in which there is a horizontal 
slot. This slot allows only a point of the shadow to pass through to a moving 
photographic plate or film, on which the point of shadow writes in a continuous 
curve. The photographic material was later developed to produce the image 
(Fig. 34, 35, 36).  
 
Fig. 34: Einthoven’s recording schema 
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Fig. 35: Einthoven’s lab setup with the string galvanometer (two views) 
 
 
Fig. 36: Einthoven’s lab and colleagues 
 
 
The signals were obtained from the two arms and left leg (modern Lead I). To 
enhance conduction, hands and foot were bathed in saline solution with the 
tubs wired to the input of the electrocardiograph (Fig.37, 38). It is interesting 
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to note that the signals were collected from a patient in the University Hospital 
and transmitted to the physiology lab (quite a good distance away) where the 
actual recording was made. An early example of telemedicine!  
 
Fig. 37: Early ECG recording technique 
 
 
Fig. 38: Early Einthoven ECG 
 
There was wide scepticism by the contemporary scientific community against 
his methods. But Einthoven continued publishing and in 1913 described the 
Einthoven triangle as the basis for calculations of electrocardiograms and 
introduced the bipolar electrode system. Classic rhythms were obtained and 
published.  
Einthoven was formal, methodical and demanded technical perfection. He 
was keen to apply the modality to clinical problems. In 1924, he was awarded 
the Nobel Prize for Physiology and Medicine for his electrocardiographic work 
in developing the string galvanometer.  
 
1933  
The extremity bipolar electrode system (the standard electrocardiogram lead 
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system) was expanded in 1933 by F. N. Wilson who introduced the unipolar 
chest wall electrodes.  
 
1942  
E. Goldberger introduced the unipolar amplified (augmented) extremity leads. 
The 12-lead electrocardiogram as we know it today was now complete!  
Several manufacturers to produced commercial versions of the 
electrocardiograph (Fig. 39). The Cambridge Scientific Instrument Co., 
headed by Horace Darwin (Charles' youngest son), produced such a device. 
The string galvanometer for electrocardiography was superceded by direct 
writing equipment after the Second World War.  
 
Fig. 39: Early ECG machine 
 
 
Electrocardiography was of paramount importance in the understanding of 
cardiac rhythm and hence in the further development of pacing.  
 
Late 1920’s – Early 1930’s: first pacing machines  
Credit for the first external cardiac pacemaker has been shared by two 
doctors: the Australian anaesthesiologist Mark Lidwell and the American 
physiologist Albert Hyman. Working independently on opposite sides of the 
world they developed the first cardiac pacing machines.  
 
1928: Mark Lidwell  
Lidwell’s device ran on alternating current and required a needle to be 
inserted into the patient’s ventricle. In 1928 he used intermittent electrical 
stimulation of the heart to save the life of a child born in cardiac arrest. The 
child apparently recovered completely and survived but not much else is 
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known of Lidwell’s efforts. He reported his work to the Third Congress of the 
Australian Medical Society in 1929.  
 
1932: Albert Hyman  
 
Hyman became interested in reviving the "stopped heart" by means of 
"intracardial (his term) therapy". Initially this therapy consisted of the intra-
cardiac injection of stimulant drugs such as epinephrine although he soon 
realised that it was not really the drug that restarted the heart but the needle 
that set up an action current of injury as it punctured the cardiac wall.  
Hyman’s device, described in 1932 (Fig.40, 41), was powered by a spring-
wound hand-cranked motor and called by Hyman himself an "artificial 
pacemaker", a term still in current use.  
 
Fig. 40: Albert Hyman’s "artificial pacemaker": the two photos 
 
 
Fig. 41: Hyman’s device in a box 
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The clockwork drove a DC current generator whose electrical impulses were 
directed into the patient’s right atrium through a bipolar needle electrode 
introduced via an intercostal space (Fig. 42, 43). Pacing could be delivered at 
rates of 30, 60 or 120 per minute. None of the three models of this device 
build in the 1930’s survives today and only two photos can be traced.  
 
Fig. 42: Hyman’s electrodes 
 
 
Fig. 43: Flow diagram of Hyman’s "artificial pacemaker" 
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Hyman’ work (Fig. 44) was frustrated and eventually derailed by technical 
problems and the attitude of the times. The medical and social community 
was not ready for electrostimulation: Hyman’s device was roundly dismissed 
as "gadgetry" that interfered with natural events at best and the work of the 
devil at worst. He faced considerable opposition, including that of the Journal 
of the American Medical Association and did not report his experiments.  
 
Fig. 44: Hyman’s recordings 
 
 
No one agreed to manufacture it locally although a battery-operated version 
(lost to history) was eventually manufactured by Siemens-Halske in Germany 
and their American subsidiary Adlanco (Fig. 45). The Hymanotor, as it was 
called, was tested but found ineffective and again unfavourably reported 
upon. During the Second World War, Hyman unsuccessfully urged the US 
Navy to support his device for use in resuscitation of dying servicemen.  
 
Fig. 45: The Hymanotor (Adlanco) 
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It is important to note that Hyman intended the pacemaker to restore a normal 
heartbeat in patients whose heart had stopped accidentally or in stillborn 
infants rather than in those with heart block. In the mid-1930’s, the connection 
between Stokes-Adams disease and pacing had not yet been made.  
 
Early 1950’s: first mains-powered portable pacemaker  
Mains-powered pacemakers were developed in the early 1950’s and were 
large bulky boxes filled with vacuum tubes that could not of course be 
implanted. They had to be wheeled around on carts and plugged into wall 
mains socket outlets to obtain their alternating current power. They were 
portable only in name since they could only go as far as the nearest electrical 
outlet!  
 
1949  
In Toronto, Canada, Wilfred Bigelow (Fig. 46) and John Callaghan started 
using hypothermia to reduce metabolism and produce bradycardia and 
asystole to permit cardiac surgery. Re-warming could not however restore 
cardiac contraction sufficiently rapidly and so the surgeons started 
experiments with sino-atrial node stimulation.  
 
Fig. 46: Wilfred Bigelow 
 
 
In 1949, during an experimental operation on a dog, the heart suddenly 
stopped. Bigelow recounts: "Out of interest and in desperation, I gave the left 
ventricle a good poke with a probe I was holding. All four chambers of the 
heart responded. Further pokes clearly indicated that the heart was beating 
normally with good blood pressure." The electric pacemaker was developed 
as a direct result of these hypothermia experiments.  
During the 1940's and early 50's the principle device available to generate a 
variety of electrical impulses, potentially capable of stimulating the heart was 
a physiological stimulator manufactured by Grass Manufacturing Co for 
clinical and physiology lab application (Fig. 47). It used a thyratron rectifier 
tube to convert alternating current into direct current suitable for stimulation of 
biologic tissue. The stimulation rate, voltage output and pulse width could be 
varied (monophasic rectangular pulse of 2- 20 ms duration).  
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Fig. 47: The Grass stimulator 
 
 
 
 
 
 
John Hopps (Fig. 48), an electrical engineer, was recruited on a part-time 
basis by the National Research Council of Canada and designed what was 
perhaps the first electronic device specifically built as a cardiac pacemaker. It 
was an external unit driven by vacuum tubes. The electrical impulses were 
transmitted via a bipolar catheter electrode to the atria using a transvenous 
approach. Atrial pacing was readily achieved and heart rate could be 
controlled with no uncomfortable chest wall contractions (Fig.49).  
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Fig. 48: John Hopps 
 
 
Fig. 49: Early external electronic pacemakers 
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1951  
Paul Zoll (Fig.50), a Boston cardiologist, is given credit for ushering in the 
modern era of clinical cardiac pacing. He had read the work done by 
Callaghan, Bigelow and Hopps and developed an external tabletop 
pacemaker that was successfully applied to the treatment of heart block (Fig. 
51).  
 
Fig. 50: Paul Zoll and a colleague 
 
 
Fig. 51: Zoll's external pacemaker 
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The electrodyne PM-65 pacemaker, designed by Zoll, comprised an 
electrocardiograph to monitor the cardiac rhythm and an electric pulse 
generator to pace the heart. The pulse generator was a modification of the 
electric stimulator used in physiology laboratories. It delivered periodic electric 
impulses at 2 ms pulse width and 50 to 150 volts alternating current pulse 
amplitude through a pair of 3 cm2 metal electrodes strapped to the patient’s 
chest directly over the heart. The electrodes irritated the skin and the patients 
of course found the repeated electric shocks painful.  
The mains-powered unit was bulky and heavy and was carried on a cart. It 
could only go as far as the extension cord would allow (Fig. 52).  
 
Fig. 52: The PM-65: historic 1958 photo (patient was using the first 
catheter electrode) 
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In 1952, he reported on two patients suffering from recurring prolonged 
ventricular standstill whom he treated with this external device (Fig. 53) and in 
1956, he applied transthoracic electric shocks to reverse ventricular fibrillation 
in humans and soon after developed the first cardiac monitors for clinical use.  
 
Fig. 53: Early Zoll paced ECG tracings 
 
 
1956  
In St. George’s Hospital, London, Aubrey Leatham (Fig. 54) and Geoffrey 
Davies developed an external stimulator with which to resuscitate patients 
with heart block and asystole. The first studies on the use of external pacing 
for cardiac standstill had just been reported by Paul Zoll in Boston; however, 
Zoll's pacemaker was a fixed system without a demand capability and could 
cause an "R on T"-induced ventricular fibrillation. At St. George's, Leatham 
asked Davies to develop the first demand circuit device which was published 
in 1956.  
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Fig. 54: Aubrey Leatham 
 
 
This mains-powered device stimulated the heart through the intact chest wall 
utilising 150 volts and was commercially manufactured by Firth-Cleveland in 
the UK. The commercial version contained several modifications: duration of 
asystole permitted, sensitivity controls to sense the electrocardiogram, two 
output ranges and a battery for independent operation.  
 
Late 1950’s – early 1960’s: The "Golden Years"  
These years witnessed several important achievements in the field of cardiac 
pacing by multiple persons and their teams working in different parts of the 
world: they were the "golden years" of pacing.  
Three landmark "firsts" will be described in detail: the first battery-operated 
wearable pacemaker (1957), the first totally implantable pacemaker (1958) 
and the first long-term correction of heart block with a self-contained, 
implantable pacemaker (1960). These events had far-reaching consequences 
and opened up the field to the future.  
 
1957: First battery-operated wearable pacemaker 
Earl E. Bakken, electrical engineer, TV repairman and co-founder of 
Medtronic Inc. produced the first battery-operated wearable pacemaker.  
 
The engineer  
Earl E. Bakken (Fig. 55) and his brother-in-law Palmer Hermundslie had co-
founded Medtronic on April 29th, 1949 in a garage in northeast Minneapolis 
(Fig. 56, 57). The company had led a precarious existence as a repair service 
for hospital electrical equipment and regional distributor for other 
manufacturers. They would build new equipment on order or customise 
standard instruments for laboratory or clinical researchers. They would hang 
around hospital surgical suites setting up equipment, training personnel in its 
use and troubleshooting and repairing it as necessary. Meanwhile they forged 
working relationships with physicians and their staff.  
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Fig. 55: Earl Bakken 
 
 
Fig. 56: Medtronic’s first building 
 
 
Fig. 57: Bakken’s first lab 
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Bakken recounts: "We never made any serious money on that early custom-
building activity, rarely even recouping the cost of the prototype… everything 
we did, we lost money on!" They were however present at the right time in the 
right place!  
The surgeon  
C. Walton Lillehei (Fig. 58) was a leading cardiac surgeon at the University of 
Minnesota, Minneapolis and had attained international fame by the mid-50’s. 
Techniques had been developed to enter the heart and correct congenital 
defects while the circulation was supported. By 1957, Lillehei had performed 
over 300 open-heart operations on young adults and children. This rapidly 
evolving field of open heart surgery was to be a major driving force towards 
the development of cardiac pacing.  
 
Fig. 58: Walton Lillehei 
 
 
 
A series of problems… resolved!  
Despite successful repair of the congenital defect, about 1 patient in 10 
developed post-operative complete heart block due to damage of the 
conducting system while the surgical repair was being performed. Stimulant 
drugs such as adrenaline, atropine, or the newly developed isoprenaline, were 
helpful in the short-term but proved disappointing over a longer time frame 
and could not prevent sudden recurrence of heart block. Another solution had 
to be found!  
It was thought that temporary rhythm support via pacing would keep the 
patient alive until recovery of the conducting system occurred. The technology 
developed by Zoll was clearly inappropriate as the high voltage pacing stimuli 
delivered trans-thoracically would be far too traumatic on these young 
children.  
The physiologist John Johnson proposed the utilisation of the Grass 
stimulator that was used in the physiology labs to activate hearts. After 
several experiments, Vincent Gott and William Weirich concluded that a 
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cardiac rhythm could be restored in animal hearts in which heart block had 
been surgically created by means of a wire inserted into the wall of the right 
ventricle and connected to the external stimulator. Low voltage pulses at the 
desired rate could easily stimulate these hearts.  
Lillehei and his co-workers developed the myocardial wire: a multi-stranded, 
braided stainless steel wire in a Teflon sleeve (Fig. 59). One end of this was 
implanted directly into the myocardium and the other end was exteriorised via 
a stab incision and connected to the physiology lab stimulator. An indifferent 
electrode was buried under the skin to complete the circuit. Effective pacing 
needed only 1.5 volts as there was direct contact with the myocardium. There 
was no rejection and no damage to the beating heart and the wire could be 
removed easily by tugging once normal conduction resumed.  
 
Fig. 59: Myocardial pacing wire and indifferent electrode 
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The first myocardial wire was implanted on the 30th January 1957 in a 3-year 
old girl in whom heart block had complicated the repair of Fallot’s tetralogy. 
Pacing was successful and the little girl soon regained sinus rhythm and 
survived. Myocardial wires started being implanted electively, ready for 
immediate use later should this become necessary. A technique for their 
implantation through a hollow needle was also developed for non-surgical 
patients who developed Stokes-Adams attacks.  
Further problems soon became obvious: the stimulator was large and heavy, 
of limited portability and awe-inspiring especially for paediatric patients. 
Moreover, the system was fatally flawed since it depended totally on its 
external mains power supply and on the length and integrity of the extension 
power cord. If power supply failed, it was worthless.  
On October 31st, 1957 a municipal power failure lasting three hours resulted in 
the tragic death of a baby. The hospital had emergency power generation in 
its surgical suites and recovery area but not in its patient rooms. The 
caregivers were once more reminded of the limitations of existing technology.  
The day after, Lillehei requested Bakken to see if Medtronic could come up 
with something better. Patient mobility needed improvement and concerns 
about power failure needed to be eliminated. When Bakken accepted 
Lillehei’s assignment, it seemed to him just like any other special order for a 
piece of equipment. This was not to be!  
 
First attempts  
Initial attempts at building a more reliable and portable pacemaker involved 
adding an automobile battery with an inverter to convert 6 volts direct current 
into 115 volts alternating current and then power the conventional alternating 
current pacemaker on its wheeled stand.  
These plans were soon abandoned, as they were obviously highly inefficient! 
A 10 volt direct current pulse was sufficient to stimulate the heart and 
transistors were becoming widely available.  
 
The prototype  
Bakken dug out the April 1956 back issue of Popular Electronics in which he 
recalled seeing a circuit for an electronic, transistorised metronome. The 
circuit transmitted clicks through a loudspeaker: the rate of the clicks could be 
adjusted to fit the music. The blocking oscillator circuit that was utilised had 
actually been invented at the MIT Radiation Laboratory during World War II.  
He simply modified the two-transistor circuit (Fig. 60) and placed it, without 
the loudspeaker, into a four-inch-square and inch-and-a-half-thick aluminium 
box with terminals and switches on the outside. The circuit was powered by a 
powerful miniature 9.4 volt mercury battery housed within the box. There was 
an on-off switch and control knobs for stimulus rate and amplitude (Fig. 61).  
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Fig. 60: Bakken’s circuit 
 
 
 
 
 
 
 
Fig. 61: Bakken’s pacemaker with leads 
 
 
 
Bakken recounts: "Without any grandiose expectations for the device, I was 
moderately optimistic about what it might eventually do for Lillehei’s patients. I 
drove the device over to the University’s animal lab where it could be tested 
on a dog. Of course it worked.  
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"The next day I returned to the hospital to work on another project when I 
happened to walk past a recovery room and spotted one of Lillehei’s patients. 
I must have done a double take when I glanced through the door. The little girl 
was wearing the prototype I had delivered only the day before! I was stunned. 
I quickly tracked down Lillehei and asked him what was going on. In his 
typical calm, measured, no-nonsense fashion he explained that he’d been told 
by the lab the pacemaker worked and he didn’t want to waste another minute 
without it. He said he wouldn’t allow a child to die because we hadn’t used the 
best technology available."  
After only 4 weeks of experimentation and work, the first battery-powered, 
transistorised pacemaker was already in clinical use! A feat that is unlikely 
ever to be repeated given the regulatory labyrinth that all devices have to go 
through from inception to clinical use.  
 
The "first ten"  
The first production run of ten or so units were more refined versions of the 
original prototype and went into clinical use soon after at the University (Fig. 
62). The dials had been recessed so that children would be less likely to 
adjust them and a little neon light blinked red with each stimulus. In addition, 
two metal handles (borrowed from an old ECG machine) were been added 
such that a strap could secure the pacemaker to the body. The pacemaker 
was not only portable but wearable! This pacemaker became known as the 
5800 (because it was made in 1958). The product literature (Fig. 63) stated 
boldly:  
"So small and light that it may be attached to and worn by the patient, the 
Medtronic Cardiac Pacemaker stimulates ventricular function in cases of atrio-
ventricular dissociation that are induced during the surgical repair of septal 
defects, or that occur spontaneously as in Stokes-Adams syndrome. The 
Pacemaker is designed for internal applications with at least one wire 
attached directly to the myocardium for temporary stimulation or with a bipolar 
patch for prolonged stimulation.  
"Created with imagination and originality, the transistorised circuit completely 
removes the hazards and nuisance associated with AC powered instruments. 
Its self-contained miniature power source will operate the instrument for 
approximately 1000 hours."  
The chosen pacemaker output was a 2 ms square wave, variable in amplitude 
from 1 to 20 mA into a 1000 W load. The blocking oscillator repetition rate 
was variable from 60 to 180 pulses per minute. The box was "wearable" 
(Fig.64).  
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Fig. 62: One of the "first ten" 
 
 
Fig. 63: Product literature of the "first ten" 
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Fig. 64: Wearable devices on patients (1958) 
 
 
The significance and the consequences  
Medical historians regard Bakken’s pacemaker is one of the first successful 
applications of transistor technology to medical devices helping to launch the 
new field of "medical electronics" (Fig.65). In the entire history of medicine 
before 1957, there had never been a partly or completely implantable 
electrical device. It was however apparent that for long-term pacing a totally 
implanted device would have to be designed as ascending infection via the 
pacing electrodes occurred frequently.  
 
Fig. 65: Lillehei with a child being paced 
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Lillehei himself noted: "The question of how long stimulation can be 
maintained appears to be related to electrode materials, design and technique 
of implantation… The possibility of infection along the wire exists, but… can 
be minimised by tunneling the wire for some distance before bringing it out on 
through the skin." (Fig. 66) Most patients with post-operative heart block 
regained sinus rhythm within a few weeks but one patient was kept on the 
device for 15 months.  
 
Fig. 66: Lillehei’s paper 
 
 
 
 
Recurrent heart block in patients who had recovered from their post-operative 
heart block caused several deaths. It was apparent that these patients 
needed indefinite and not temporary pacing for them to survive. The 
myocardial wire developed exit block as scar tissue grew around the site of 
stimulation increasing electrical resistance and requiring a progressive 
increase in pacing stimulus voltage to maintain capture. The thoracic muscles 
began to twitch at these increased voltages. A totally implantable system with 
better designed elctrodes neede to be designed!  
Meanwhile elsewhere, on the 16th July 1958 a transvenous catheter electrode 
was introduced fluoroscopically, via the basilic vein into the right ventricular 
outflow tract, in a patient with fixed complete heart block who required colon 
resection because of a malignancy. Pacing was continued for two hours, 
during the operative procedure, and ended with slowing of the stimulation rate 
until an unpaced idioventricular rhythm developed. The catheter was removed 
without complication and the patient resumed the idiventricular bradycardia.  
 
O Aquilina. A brief history of cardiac pacing. Images Paediatr Cardiol. 2006 Apr-Jun; 8(2): 17–81.  
 56 
1958: First implantable pacemaker  
On October 8th, 1958 the first pacemaker implantation was performed in 
Sweden. The system had been developed by the surgeon Ake Senning and 
the physician inventor Rune Elmqvist and implanted on a 43-year old 
engineer called Arne Larsson. This first experience with a fully implantable 
pacemaker system was reported at the Second International Conference on 
Medical electronics in 1959 and published as an abstract in 1960 (Fig. 67).  
 
Fig. 67: Senning’s and Elmqvist’s paper 
 
 
 
 
The patient suffered from Stokes-Adams attacks that required resuscitation 
many times daily and whose situation was considered hopeless. The 
implantation was a more or less desperate rescue measure. The risks taken 
with this completely unknown therapy were immense.  
 
O Aquilina. A brief history of cardiac pacing. Images Paediatr Cardiol. 2006 Apr-Jun; 8(2): 17–81.  
 57 
The scientists  
Ake Senning (Fig. 68) was the cardiac surgeon in charge of the Department of 
Thoracic Surgery at the Karolinska Hospital in Stockholm. He had observed 
Lillehei's work with temporary external pacing.  
 
Fig. 68: Ake Senning 
 
 
Rune Elmqvist (Fig. 69) was a medical graduate who had not pursued a 
medical practice but became an engineer. He had designed a portable ECG 
machine in 1931 and then the widely used ink jet recorder, the Mingograf, in 
1948.  
 
Fig. 69: Rune Elmqvist 
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These two men began to collaborate closely in 1950 and developed fibrillators 
and defibrillators for open heart surgery. They realised that the main problem 
with external pacemakers was the open route for ascending infection along 
the lead and decided to design a fully implantable system.  
 
The patient  
Arne Larsson (Fig. 70) is the first human to receive an implanted pacemaker. 
He had been hospitalised with complete heart block and frequent Stokes-
Adams attacks for 6 months. He was having 20 to 30 attacks daily and his 
prognosis was poor. Treatment was maximised with ephedrine, pentymal, 
atropine, isoprenaline, caffeine, digoxin and whisky.  
 
Fig. 70: Arne Larsson 
 
 
The woman: Else Marie Larsson  
Else Marie was the patient's wife who pleaded with Elmqvist and Senning to 
help her hopelessly ill husband. She had read press reports about ongoing 
experiments with electrical stimulation of the heart and hounded down the two 
scientists for a solution that did not yet exist: an implantable pacemaker.  
Senning recounts his encounter with this lady: "An energetic, beautiful woman 
entered my lab on the 6th October 1958 and told me that I had to implant a 
pacemaker into her husband. I told her we had not completed our 
experimental series and we did not have a pacemaker for human clinical 
implantation. She demanded: ‘So make one!’. That day she drove several 
times from Elmquist’s electronic lab and back and finally convinced us."  
 
The procedure  
To avoid publicity, the implantation was done in the evening when the 
operating rooms were empty. Via a left-sided thoracotomy two suture 
electrodes were implanted into the myocardium and tunnelled to the 
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pacemaker box placed in the abdominal wall. The first pacemaker implanted 
functioned only a few hours but the second one implanted in the same patient 
had better longevity.  
Senning recounts: "On the 8th October 1958, in the evening, when there were 
no extra people in the theatre, I implanted the first pacemaker, but it lasted 
only 8 hours. Presumably, I had damaged the output transistor or capacitance 
with the catheter and I did not have the other one which was in the lab. I 
implanted the other one early the next morning". Senning then concludes: "In 
the 1950’s we did not have any liability problems. The patient and relatives 
were happy if the patient survived."  
The second pacemaker functioned well for about 1 week before suddenly 
showing a decrease in the ECG pacing stimulus size: suggesting probable 
lead fracture rather than pulse generator malfunction.  
 
The circuit  
The pulse generator delivered impulses at an amplitude of 2 volts and a pulse 
width of 1.5 ms. The pulse rate was fixed at a constant rate of 70 to 80 beats 
per minute. The energy utilised was minimised since Elmqvist managed to 
obtain a few of the first silicon transistors imported into Sweden. These were 
more efficient than the older germanium transistors. With them Elmqvist 
designed a stable and efficient blocking oscillator with a small power 
consumption (Fig.71).  
 
Fig. 71: Elmqvist’s circuit 
 
The first transistor forms a repetitive blocking oscillator whose pulses are fed 
to the base of the second transistor. the collector of this second transistor is 
then connected to the pacing electrode over an RC network.  
Several types of primary battery cells could have been used. The Ruben-
Mallory cells with zinc as the anode and mercuric-oxide as the depolarizer 
were a possible choice (Fig. 72). They had been invented during World War II 
for army field telephones. Although the cell potential remained constant, these 
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cells had a short lifetime and released hydrogen gas at the zinc anode. The 
effect of this gas in a cell encapsulated in plastic was not known. For these 
reasons, nickel-cadmium rechargeable cells were then chosen. Two cells of 
60 mAh each were sealed, encapsulated and connected in series.  
 
Fig. 72: Mercury Cell 
 
Recharging was accomplished inductively. A coil antenna with a diameter of 
about 50 mm was connected to the cells via a silicon diode. This was 
inductively coupled across the patient’s skin to a large external flexible coil 25 
cm in diameter attached to the patient's abdomen with adhesive tape. 
Recharging was accomplished by a 150 kHz radio frequency current 
generated by an external mains-powered vacuum tube device connected to 
the external coil. The pacemaker required charging once a week for 12 hours.  
 
The device  
The entire unit was entirely hand-made (Fig. 73) and consisted of the nickel-
cadmium batteries, the electronic circuit and the coil recharging antenna. 
These were encapsulated in a new epoxy resin (Araldite) produced by Ciba-
Geigy, which had excellent biocompatibility. The approximate diameter and 
thickness became 55 mm and 16 mm respectively, according to the 
dimensions of the ever so popular shoe polish can from Kiwi (Fig. 74). 
Elmquist in fact produced two such units using these cans as moulds!  
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Fig. 73: First implanted pacemaker 
 
 
 
Fig. 74: Kiwi Shoe Polish 
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These first units had two electrode wires, each consisting of a twinned, 
stainless steel suture wire with polyethylene insulation. The distal ends of the 
wires were sewn into the myocardium to act as pacing electrodes. The 
proximal ends were hard-wired to the pulse generator circuit. It was estimated 
that the electrode had to withstand about 105 bends per day (Fig. 75, 76).  
 
 
 
 
 
Fig. 75: Modern replica of Elmqvist’s pacemaker 
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Fig. 76: X-ray of Larsson showing pacemaker and leads 
 
 
 
 
 
 
 
 
The personal outcome  
Rune Elmqvist soon ceased his involvement in pacing but remained active in 
other areas of medical technology. He died in 1997, aged 90. Ake Senning 
remained very active in the field of cardiac surgery. He died in 2000 at the age 
of 84. Arne Larsson survived both the engineer as well as the surgeon who 
had saved his life (Fig. 77). He required five lead systems and 22 pulse 
generators of 11 different models until his death on December 28th 2001 aged 
86 of a malignancy totally unrelated to his conduction tissue disease or his 
pacemaker system.  
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Fig. 77: Elmqvist, Senning and Larsson (left to right) 
 
 
1960: The first long-term correction of complete heart block  
Wilson Greatbatch  
Wilson Greatbatch was an electrical engineer teaching at the University of 
Buffalo where he was working on an oscillator to aid in the recording of 
tachycardias. He accidentally discovered the way to make an implantable 
pacemaker (Fig. 78).  
 
Fig. 78: Wilson Greatbatch and his circuit 
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Greatbatch, a deeply religious man, describes the event this way: "It was no 
accident, the Lord was working through me… The oscillator required a 10 KW 
resistor at the transistor base. I reached into my resistor box for one, but I 
misread the color coding and got a 1 MW resistor by mistake."  
When he plugged in the resistor, the circuit started to "squeg" with a 1.8 
millisecond pulse followed by a 1 second interval during which the transistor 
was cut off and drew practically no current. "I stared at the thing in disbelief," 
he said. Wilson Greatbatch immediately realized that this small device could 
drive a human heart but it wasn’t easy to find a heart surgeon who would 
believe in his idea.  
 
Dr. William Chardack  
Dr. William Chardack was chief of surgery at Buffalo’s Veteran’s Hospital at 
the time. In Dr. Chardack, Greatbatch had finally found a surgeon who 
believed in the viability of an implantable pacemaker.  
On May 7, 1958, Greatbatch brought what would become the world’s first 
implantable pacemaker to the animal lab at the hospital. There, Chardack and 
another surgeon, Dr. Andrew Gage, exposed the heart of a dog to which they 
touched the two pacing wires. The heart proceeded to beat in synchrony with 
the device. The three looked at each other. Their feelings were best 
expressed by Dr. Chardack, who exclaimed, "Well, I’ll be damned."  
In a lab book about a year later, Greatbatch wrote "I seriously doubt if 
anything I ever do will give me the elation I felt that day when a 2 cubic inch 
electronic device of my own design controlled a living heart."  
 
The "bow tie team" (Fig. 79)  
The three - Greatbatch and Drs. Chardack and Gage - became known as the 
bow tie team. "The two doctors wore bow ties because children tend to pull 
long ties. I wear bow ties because long ties get in the way when I am 
soldering." The months and years that followed involved a great deal of 
research and experimentation. "I frequently took problems to the Lord in 
prayer," Greatbatch says, "and I always got the answer."  
 
Fig. 79: The "Bow Tie Team" 
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Over the first two years experiments were made with animals. In 1959, 
Greatbatch patented the implantable pacemaker, and William Chardack 
reported the first success in a human with this unit in 1960. The procedure 
was completed in June 1960 on a 77-year old man in complete heart block 
(Fig. 80). Chardack first implanted the lead and when threshold stabilised 
implanted the pulse generator. The patient survived uneventfully for 2 years 
before his death from natural causes.  
 
Fig. 80: Patient with Greatbatch’s pacemaker 
 
 
In 1961, Chardack, Gage and Greatbatch reported a series of 15 patients who 
had pacemakers implanted. Greatbatch later invented the long-life corrosion-
free lithium-iodine battery to power the pacemaker (Fig. 81).  
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Fig. 81: Lithium-Iodine Cell 
 
 
The global outcome  
The early pacing technology of the 1950’s and 1960’s was a spin-off from the 
research and development of World War II and Cold War eras.  
Faulty batteries, body fluids leaking into the encasement and broken leads 
caused numerous pacemaker failures that required emergency surgery. The 
main difficulty however was the lead. It was soon obvious that the myocardial 
wire was unsuitable as a long-term electrode. Stimulation threshold increased 
after a few weeks until exit block developed and no more capture was 
possible. Moreover, the wire could not resist the enormous repetitive 
mechanical stresses of bending. These technical problems contributed to the 
delay in the widespread use of implanted pacemakers for several years.  
Tight collaboration between engineers, physicians and patients was the 
fundamental driving force for the growth of a significant global industry. Well 
over 2 million pacemakers have been implanted worldwide since 1960!  
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 Zoll founded Electrodyne and continued developing pacemakers.  
 Earl Bakken (co-founder of Medtronic Inc.) started producing the 
Chardiack-Greatbatch pacemaker.  
 Wilson Greatbatch, after a time with Medtronic, founded his company 
(Wilson Greatbatch Ltd.) and convinced the industry to change from 
mercury to lithium-iodine cells.  
 The company Elema Schonander, for which Rune Elmqvist worked, 
became Siemens-Elema in 1974. Siemens then acquired Pacesetter 
Inc. in 1985 and combined them to form Siemens-Pacesetter which 
was then in turn acquired by St. Jude Medical in 1994  
1958-1959: Inductively coupled cardiac pacemakers  
Other investigators followed a different line of approach in designing self-
contained implantable pacemakers: inductive coupling (Fig. 82).  
 
Fig. 82: Inductively-coupled pacing 
 
 
A pair of electrodes were sutured to the epicardium and connected to a coil 
antenna located subcutaneously. Minimal or no circuitry was implanted and 
no internal batteries were needed.  
This coil antenna was inductively coupled to an external coil taped to the 
patient’s intact skin. This external coil was connected in turn to a 
transistorised pulse generator powered by an external battery. The electronic 
components, relatively unreliable at this time, were therefore located entirely 
outside the body.  
O Aquilina. A brief history of cardiac pacing. Images Paediatr Cardiol. 2006 Apr-Jun; 8(2): 17–81.  
 69 
Glenn, Mauro, Longo, Lavietes and Mackay’s technique utilised a radio-
frequency oscillator . Later versions of this system included triple-helix, 
silicone insulated endocardial leads and rate-control via an external knob 
(which the patient himself could modify at will). Atrial pacing with this device 
was used in 1969.  
Inductively-coupled pacemakers proved to be very successful with several 
hundreds of implants and survival rates of over 10 years (Fig. 83). These 
devices were extensively used in the Birmingham (UK) region for a number of 
years, being produced by the Lucas factory, more commonly known for its 
automotive electrical products (until taken over by Bosch). One particular 
disadvantage of this device was that its removal (for example, for bathing) 
could result in bradycardia and syncope. They continued to be used until well 
into the 1970’s and several patients with later generation pacemakers still 
have the implanted coils from their original devices.  
 
Fig. 83: External coil and device for inductive device 
 
 
1959: Hunter – Roth electrode  
On the 4th April 1959 Samuel Hunter (Professor of Surgery at St. Paul) and 
Norman Roth (Chief Engineer at Medtronic) implanted a bipolar stainless steel 
electrode to pace a patient suffering from post-myocardial infarction complete 
heart block (Fig. 84). The lead consisted of a pair of stainless steel wires 
secured in a silicone rubber base (Fig. 85).  
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Fig. 84: Warren Mauston, the first recipient of the Hunter-Roth electrode 
 
 
Fig. 85: Hunter-Roth electrodes 
 
 
1959: Elema-Ericsson lead  
A new lead was developed in 1959 by Elema Schonander and the Telecom 
Company, Ericcson. This consisted of four thin bands of stainless steel wound 
around a core of polyester braid and insulated with soft polyethylene (Fig. 86). 
It was estimated to resist over 184 million flex cycles, hence lasting for at least 
6 years. The unipolar epicardial stimulation electrode was a platinium disc, 
8mm in diameter and insulated at the back.  
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Fig. 86: Elema lead 
 
 
 
 
1959 - 1960: Elema Schonander  
The Elema 135 (Fig. 87) rechargeable pacemaker was successfully implanted 
in Stockholm (1959), Uruguay (February 1960) and England (March 1960) but 
Elema Schonander never filed a patent application. The maket prospects 
were perceived to be poor! Pacemakers were considered as an expensive 
service to prominent customers with little commercial value. The external 
charging system was too complicated especially for elderly patients.  
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Fig. 87: The Elema 135 
 
 
Elmqvist constructed the Elema 137 pacemaker in 1960 (Fig. 88). Ruben-
Mallory zinc-mercury oxide cells were used as the power source thus 
eliminating the need for periodic recharging of the previously utilised nickel-
cadmium cells.  
 
Fig. 88: The Elema 142 (with non-rechargable cells) 
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Early 1960’s  
Other models were implanted with similar success in 1961 by Zoll et al (Fig. 
89) and in 1962 by Kantrowitz et al. The technique for inserting permanent 
transvenous bipolar pacing electrodes was developed in 1962 by Parsonnet 
et al. (in the US) and by Ekstrom et al. (in Sweden).  
 
Fig. 89: Zoll device 
 
 
 
 
 
Recent history  
Pacemaker and lead technology continued to develop rapidly to make these 
devices reliable, automatic and flexible in the therapy they provide. The 
therapeutic end-point shifted from saving life to enhancing its quality and 
simplifying follow-up. Electrotherapy has become socially accepted and its 
indications are extending also to non-cardiac pathology: Parkinson’s Disease, 
pain-control, drug delivery.  
 
Mid 1960’s (Fig. 90)  
Transvenous leads replaced epicardial leads. Pacemakers and their leads 
could be implanted without a thoracotomy and without general anaesthesia. 
"Demand" pacemakers were developed to sense the underlying cardiac 
activity and provide pacing only when needed.  
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Fig. 90: Devices of the 60’s 
 
 
1970’s  
Lead design improved: "tined" for passive fixation and "screw-in" for active 
fixation. The lithium-iodine battery was developed to replace the mercury 
oxide-zinc battery that had been used till then. This resulted in greatly 
increased pacemaker longevity (Figs. 91 and 92).  
 
Fig. 91: Devices of the 70’s 
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Fig. 92: Modern lithium pacemaker cell 
 
 
In 1972 an American-made radioisotope pacemaker was implanted by 
Parsonnet et al. These nuclear pacemakers had an expected life of 20 years 
but went out of fashion mainly due to the need for extensive regulatory 
paperwork (Fig. 93).  
 
Fig. 93: Nuclear pacemakers with projected longevity 
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Titanium casing was developed to enclose the battery and circuitry. This 
replaced the epoxy resin and silicone rubber that was previously utilised to 
encase the internal components of the pacemaker.  
Pacemakers were made non-invasively programmable in the mid-1970’s. 
Using a radio-frequency telemetry link, most pacing parameters could be 
adjusted to follow the changing clinical needs of the patient.  
By the end of the 70’s dual-chamber pacemakers were developed to pace 
and sense in both atria and ventricles. Synchronised timing made it possible 
to preserve the atrial contrbution to ventricualar filling as well as to track the 
intrinsic atrial rate.  
 
1980’s  
In the early 1980’s steroid-eluting leads were developed. These eluted steroid 
from their tip and hence decreased the inflammatory response evoked by the 
presence of the lead tip (acting as a foreign body). Consequently, the early 
rise of capture threshold was blunted and safety was enhanced (Fig. 94).  
 
Fig. 94: Devices of the 80’s 
 
 
In 1981, Zoll patented and re-introduced a transcutaneous external 
pacemaker with a longer pulse width of 40 ms and a larger electrode surface 
area of 80 cm2. This reduced the current necessary to capture the heart and 
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thus improved patient comfort. This method of pacing could be applied very 
rapidly as a bridge to a the establishment of pacing via the transvenous route.  
In the mid-1980’s rate-responsive pacemakers were designed. A tiny sensor 
within the pacemaker box detected body movement and used this as a 
surrugate measure of activity. Signals from the sensor were filtered and 
applied to an algorithm to alter the pacing rate up or down. Thus, pacing rate 
would change according to the patient’s activity level.  
 
1990’s  
Microprocessor-driven pacemakers appeared. These became very complex 
devices capable of detecting and storing events utilising several algorithms. 
They delivered therapy and modified their internal pacing parameters 
according to the changing needs of the patient in an automatic manner. The 
rate-response pattern also adjusted itself automatically to the patient’s activity 
level (Fig. 95).  
 
Fig. 95: Devices of the 90’s 
 
 
2000’s  
Bi-ventricular pacing for heart failure was introduced. An additional specially-
designed lead was introduced via the coronary sinus to the epicardial surface 
of the left ventricle. The right ventricle (via the standard lead) and the left 
ventricle were paced simultaneously to attempt to resynchronise contraction 
of the left ventricular septum and left ventricular lateral walls. The improved 
contraction improved symptoms and survival (fig. 96).  
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Fig. 96: Contemporary devices 
 
 
Automaticity progressively increased thus making follow-up visits easier and 
briefer. Pacemakers could also upload data telephonically to a central server 
via the internet (Fig. 97).  
 
Fig. 97: Home monitoring via the World Wide Web 
 
 
Conclusion  
The history of pacing (Fig. 98) is an exciting story of initiative and innovation, 
often in the face of criticism and opposition. It is a unique mix of medicine, 
technology and marketing which has developed into a major industry and has 
brought electrotherapy out of the labs and into the clinics.  
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Fig. 98: History of pacing 
 
 
 
 
 
 
Perhaps the single most important event that enabled the development of this 
form of therapy was the invention of the transistor in December 1947 (Fig. 
99). Indeed one of the first applications of the newly invented device was in 
the nascent field of medical electronics, and particularly in pacemakers.  
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Fig. 99: The "star" of pacing: the first transistor 
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